Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Transenterix Inc (NYSE American:TRXC)

2.81
Delayed Data
As of Oct 16
 +1.35 / +92.47%
Today’s Change
0.45
Today|||52-Week Range
3.05
+116.15%
Year-to-Date

Today’s Trading

Previous close1.46
Today’s open2.78
Day’s range2.15 - 3.05
Volume80,582,016
Average volume (3 months)2,198,635
Market cap$216.9M
Dividend yield--
Data as of 10/16/2017

Growth & Valuation

Earnings growth (last year)-81.36%
Earnings growth (this year)+17.71%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales96.01
Price/Book1.43

Competitors

 Today’s
change
Today’s
% change
TTOOT2 Biosystems Inc+0.05+1.19%
SPNESeaSpine Holdings Co...-0.45-4.20%
NVTRNuvectra Corp0.000.00%
OBLNObalon Therapeutics ...+0.04+0.42%
Data as of 10/16/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$1.5M
Annual profit (last year)-$120.0M
Net profit margin-7,898.62%

Profile

Sector
Commercial Services
Industry
Miscellaneous Commercial Services
President, Chief Executive Officer &
Director
Todd M. Pope
Chief Operating Officer
Anthony Fernando
Corporate headquarters
Morrisville, North Carolina

Forecasts